VIR
Vir Biotechnology Inc
$8.1
Earnings Summary
Revenue | $16.79Mn |
Net Profits | $-115.97Mn |
Net Profit Margins | -690.85% |
Highlights
Vir Biotechnology Inc’s revenue fell -22.96% since last year same period to $16.79Mn in the Q4 2023. On a quarterly growth basis, Vir Biotechnology Inc has generated 509.64% jump in its revenue since last 3-months.
Vir Biotechnology Inc’s net profit fell -14.14% since last year same period to $-115.97Mn in the Q4 2023. On a quarterly growth basis, Vir Biotechnology Inc has generated 29.03% jump in its net profits since last 3-months.
Vir Biotechnology Inc’s net profit margin fell -48.15% since last year same period to -690.85% in the Q4 2023. On a quarterly growth basis, Vir Biotechnology Inc has generated -117.32% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Vir Biotechnology Inc post its latest quarter earnings
EPS Estimate Current Quarter | -1.05 |
EPS Estimate Current Year | -1.05 |
Highlights
Vir Biotechnology Inc’s earning per share (EPS) estimates for the current quarter stand at -1.05 - a -3.96% fall from last quarter’s estimates.
Vir Biotechnology Inc’s earning per share (EPS) estimates for the current year stand at -1.05.
Key Ratios
Key ratios of the Vir Biotechnology Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.86 |
Highlights
Vir Biotechnology Inc’s earning per share (EPS) fell -13.16% since last year same period to -0.86 in the Q4 2023. This indicates that the Vir Biotechnology Inc has generated -13.16% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-03 | -1.21 | -1.22 | -0.83% |
2023-08-04 | -1.2 | -1.45 | -20.83% |
2023-05-08 | -0.87 | -1.06 | -21.84% |
2024-02-26 | -1.01 | -0.86 | 14.85% |
₹0 US Stocks a/c Opening Fee